Skip to main content
. 2014 Sep 30;30(10):988–995. doi: 10.1089/aid.2014.0181

FIG. 4.

FIG. 4.

Changes in percentage of CD4+ T cells versus changes in proinflammatory blood biomarkers during the study. Changes in the biomarkers and CD4% T cells between the start and end of placebo/probiotic administration are plotted against each other.

HHS Vulnerability Disclosure